Hydroxyurea therapy in chronic myeloid leukemia
Agarwal, M.B.; Mehta, B.C.
Journal of the Association of Physicians of India 30(7): 427-428
1982
ISSN/ISBN: 0004-5772 PMID: 6963263 Document Number: 190462
Document emailed within 1 workday
Related Documents
Soppi, E.; Lahtinen, R. 1988: Salmonella-induced reactive arthritis in a chronic myeloid leukemia patient on hydroxyurea and interferon-alpha Clinical and Experimental Rheumatology 6(4): 425-426Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Tricot, G.; Weber, G. 1996: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity Anticancer Research 16(6a): 3341-3347
Hochhaus, A.; Berger, U.; Reiter, A.; Lahaye, T.; Kreil, S.; Hehlmann, R.üd. 2002: Drug therapy of chronic myeloid leukemia Medizinische Klinik 97(Suppl 1): 7-15
Salesi, N.; Bossone, G.; Della Longa, G.; Di Cocco, B. 2003: A new drug in the therapy of chronic myeloid leukemia: ST1571 Minerva Medica 94(2): 71-76
Richter, J.; Stenke, L. 2017: Chronic myeloid leukemia – a model disease for targeted therapy Lakartidningen 114
Mayer, J.; Zácková, D.; Klamová, H.; Doubek, M. 2008: Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches Casopis Lekaru Ceskych 147(4): 206-210
Ezaki, K. 2000: Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Dasović-Knezević, M.; Knezević, A.; Dujella, J.; Penzar, M. 1984: Development of mucormycosis infection during therapy of chronic myeloid leukemia in the acute stage Medicinski Pregled 37(11-12): 529-531
Molnár, L.; Nagy, A.; Dávid, M.; Szomor, A.ád.; Méhes, G.áb.; Kovács, G.áb.; Losonczy, H. 2004: Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha Orvosi Hetilap 145(17): 901-907
Stamatović, D.; Balint, B.; Tukić, L.; Elez, M.; Tarabar, O.; Todorović, M.; Todorić-Zivanović, B.; Ostojić, G.; Tatomirović, Z.; Marjanović, S.; Malesević, M. 2012: Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy Vojnosanitetski Pregled 69(1): 37-42
De Lord, C.; Clutterbuck, R.D.; Powles, R.L.; Min, T.; Titley, J.C.; Millar, J.L. 1993: Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy Experimental Hematology 21(6): 826-828
Groffen, J.; Voncken, J.W.; van Schaick, H.; Heisterkamp, N. 1992: Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia Leukemia 6(Suppl 1): 44-46
Kane, S.B.; Advani, S.H.; Gopal, R.; Nair, C.N.; Saikia, T.K.; Kamat, D.M. 1985: Chronic myeloid leukemia blast crisis presenting with meningeal leukemia Journal of the Association of Physicians of India 33(3): 240-241
Baccarani, M. 1998: SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768 Leukemia 12(7): 1168-1170
Yenerel, M.N.; Hatemi, I.; Keskin, H. 1999: Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis Haematologica 84(8): 766-767
Tsuberi, B.; Naparstek, E. 1995: Modification of M1 cells by exogenous introduction of IL6 gene: a model for gene therapy of acute and chronic myeloid leukemia in mice Leukemia 9(Suppl): S93-S97
Lo Coco, F.; Mandelli, F.; Diverio, D.; Alimena, G.; De Fabritiis, P.; Meloni, G.; Cedrone, M.; Frontani, M.; Guerrasio, A.; Saglio, G. 1990: Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion Bone Marrow Transplantation 6(4): 253-258